These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 27585283)

  • 1. Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases.
    Siriwardena SU; Chen K; Bhagwat AS
    Chem Rev; 2016 Oct; 116(20):12688-12710. PubMed ID: 27585283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Interaction Map of APOBEC3 Enzyme Family Reveals Deamination-Independent Role in Cellular Function.
    Jang GM; Annan Sudarsan AK; Shayeganmehr A; Prando Munhoz E; Lao R; Gaba A; Granadillo Rodríguez M; Love RP; Polacco BJ; Zhou Y; Krogan NJ; Kaake RM; Chelico L
    Mol Cell Proteomics; 2024 May; 23(5):100755. PubMed ID: 38548018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition for DNA binding between the genome protector replication protein A and the genome modifying APOBEC3 single-stranded DNA deaminases.
    Wong L; Sami A; Chelico L
    Nucleic Acids Res; 2022 Nov; 50(21):12039-12057. PubMed ID: 36444883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytidine deaminase APOBEC3C has unique sequence and genome feature preferences.
    Brown GW
    Genetics; 2024 Aug; 227(4):. PubMed ID: 38946641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I.
    Yousefi M; Annan Sudarsan AK; Gaba A; Chelico L
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOBECs and virus restriction.
    Harris RS; Dudley JP
    Virology; 2015 May; 479-480():131-45. PubMed ID: 25818029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.
    Butt Y; Sakhtemani R; Mohamad-Ramshan R; Lawrence MS; Bhagwat AS
    Nat Commun; 2024 Mar; 15(1):2369. PubMed ID: 38499553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of distinct APOBEC/ADAR mRNA levels in mutational signatures linked to aging and ultraviolet radiation.
    Niavarani A
    Sci Rep; 2024 Jul; 14(1):15395. PubMed ID: 38965255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles.
    Ajoge HO; Renner TM; Bélanger K; Greig M; Dankar S; Kohio HP; Coleman MD; Ndashimye E; Arts EJ; Langlois MA; Barr SD
    Nat Commun; 2023 Jan; 14(1):16. PubMed ID: 36627271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.
    Carpenter MA; Temiz NA; Ibrahim MA; Jarvis MC; Brown MR; Argyris PP; Brown WL; Starrett GJ; Yee D; Harris RS
    PLoS Genet; 2023 Nov; 19(11):e1011043. PubMed ID: 38033156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.
    Bogerd HP; Wiegand HL; Hulme AE; Garcia-Perez JL; O'Shea KS; Moran JV; Cullen BR
    Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8780-5. PubMed ID: 16728505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice deficient in APOBEC2 and APOBEC3.
    Mikl MC; Watt IN; Lu M; Reik W; Davies SL; Neuberger MS; Rada C
    Mol Cell Biol; 2005 Aug; 25(16):7270-7. PubMed ID: 16055735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein interaction map of APOBEC3 enzyme family reveals deamination-independent role in cellular function.
    Jang GM; Sudarsan AKA; Shayeganmehr A; Munhoz EP; Lao R; Gaba A; Rodríguez MG; Love RP; Polacco BJ; Zhou Y; Krogan NJ; Kaake RM; Chelico L
    bioRxiv; 2024 Feb; ():. PubMed ID: 38370690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A real-time biochemical assay for quantitative analyses of APOBEC-catalyzed DNA deamination.
    Belica CA; Carpenter MA; Chen Y; Brown WL; Moeller NH; Boylan IT; Harris RS; Aihara H
    J Biol Chem; 2024 Jun; 300(6):107410. PubMed ID: 38796062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA mismatch and damage patterns revealed by single-molecule sequencing.
    Liu MH; Costa BM; Bianchini EC; Choi U; Bandler RC; Lassen E; Grońska-Pęski M; Schwing A; Murphy ZR; Rosenkjær D; Picciotto S; Bianchi V; Stengs L; Edwards M; Nunes NM; Loh CA; Truong TK; Brand RE; Pastinen T; Wagner JR; Skytte AB; Tabori U; Shoag JE; Evrony GD
    Nature; 2024 Jun; 630(8017):752-761. PubMed ID: 38867045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring APOBEC3A protein levels in human cancer cells.
    Dananberg A; Maciejowski J
    Methods Cell Biol; 2024; 182():313-327. PubMed ID: 38359985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cytidine deaminases on innate immune responses against human viral infections.
    Vieira VC; Soares MA
    Biomed Res Int; 2013; 2013():683095. PubMed ID: 23865062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary effects of the AID/APOBEC family of mutagenic enzymes on human gamma-herpesviruses.
    Martinez T; Shapiro M; Bhaduri-McIntosh S; MacCarthy T
    Virus Evol; 2019 Jan; 5(1):vey040. PubMed ID: 30792902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomorphic mutation in the large subunit of replication protein A affects mutagenesis by human APOBEC cytidine deaminases in yeast.
    Dennen MS; Kockler ZW; Roberts SA; Burkholder AB; Klimczak LJ; Gordenin DA
    G3 (Bethesda); 2024 Aug; ():. PubMed ID: 39150943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomorphic mutation in the large subunit of replication protein A affects mutagenesis by human APOBEC cytidine deaminases in yeast.
    Dennen MS; Kockler ZW; Roberts SA; Burkholder AB; Klimczak LJ; Gordenin DA
    bioRxiv; 2024 Jul; ():. PubMed ID: 38979205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.